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Abstract
Background: Subclinical inflammation is a common phenomenon in patients on either continuous ambulatory
peritoneal dialysis (CAPD) or maintenance hemodialysis (MHD). We hypothesized that vitamin C had anti-
inflammation effect because of its electron offering ability. The current study was designed to test the relationship
of plasma vitamin C level and some inflammatory markers.
Methods: In this cross-sectional study, 284 dialysis patients were recruited, including 117 MHD and 167 CAPD
patients. The demographics were recorded. Plasma vitamin C was measured by high-performance liquid
chromatography. And we also measured body mass index (BMI, calculated as weight/height
2), Kt/V, serum albumin,
serum prealbumin, high-sensitivity C-reactive protein (hsCRP), ferritin, hemoglobin. The relationships between
vitamin C and albumin, pre-albumin and hsCRP levels were tested by Spearman correlation analysis and multiple
regression analysis.
Patients were classified into three subgroups by vitamin C level according to previous recommendation [1,2]
in MHD and CAPD patients respectively: group A: < 2 ug/ml (< 11.4 umol/l, deficiency), group B: 2-4 ug/ml
(11.4-22.8 umol/l, insufficiency) and group C: > 4 ug/ml (> 22.8 umol/l, normal and above).
Results: Patients showed a widely distribution of plasma vitamin C levels in the total 284 dialysis patients. Vitamin
C deficiency (< 2 ug/ml) was present in 95(33.45%) and insufficiency (2-4 ug/ml) in 88(30.99%). 73(25.70%) patients
had plasma vitamin C levels within normal range (4-14 ug/ml) and 28(9.86%) at higher than normal levels
(> 14 ug/ml). The similar proportion of different vitamin C levels was found in both MHD and CAPD groups.
Plasma vitamin C level was inversely associated with hsCRP concentration (Spearman r = -0.201, P = 0.001)
and positively associated with prealbumin (Spearman r = 0.268, P < 0.001), albumin levels (Spearman r = 0.161,
P = 0.007). In multiple linear regression analysis, plasma vitamin C level was inversely associated with log10hsCRP
(P = 0.048) and positively with prealbumin levels (P = 0.002) adjusted for gender, age, diabetes, modality of dialysis
and some other confounding effects.
Conclusions: The investigation indicates that vitamin C deficiency is common in both MHD patients and CAPD
patients. Plasma vitamin C level is positively associated with serum prealbumin level and negatively associated with
hsCRP level in both groups. Vitamin C deficiency may play an important role in the increased inflammatory status
in dialysis patients. Further studies are needed to determine whether inflammatory status in dialysis patients can be
improved by using vitamin C supplements.
* Correspondence: zuolimd@gmail.com
1Renal Division, Department of Medicine, Peking University First Hospital,
Peking, PR China
Full list of author information is available at the end of the article
Zhang et al. BMC Nephrology 2011, 12:18
http://www.biomedcentral.com/1471-2369/12/18
© 2011 Zhang et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Background
Because of its low molecular weight and high water
solubility, vitamin C could be easily cleared from plasma
during dialysis [3,4]. As important antioxidants, vitamin
C was prominently consumed because of oxidative stress
and inflammation in patients on dialysis, which could
also cause low vitamin C level [5]. It is well established
that plasma vitamin C level was generally low in patients
on dialysis [3,6-8] compared with general population. In
patients on dialysis, low plasma vitamin C level was
associated with increased risk of cardiovascular morbid-
ity and mortality [9].
Because of the bio-incompatibility, caused by mem-
brane-blood contact and dialysate- blood contact, there
were usually excess reactive oxygen species (ROS; e.g.
hydroxyl radical, hydrogen peroxide and superoxide)
production [10,11]. Furthermore, since various pro-
inflammatory cytokines were promoted due to metabolic
acidosis [12], volume overload [13], and non-sterile dia-
lysate [14], patients were usually on mirco-inflammation
status [15,16]. On the other side, antioxidant levels,
such as plasma vitamin C level and reduced glutathione
level, were usually decreased [3,5,17,18]. It was docu-
mented that inflammation was associated with increased
risk of cardiovascular morbidity and mortality in
patients on dialysis [19,20].
Evidences showed that low prealbumin level was asso-
ciated with worse survival in patients on dialysis [21,22].
It was also reported that inflammation caused low preal-
bumin level [23,24]. But the relationship between plasma
vitamin C and each of inflammatory markers and preal-
bumin was lacking, hence, we designed this study to
pursue the relationship between vitamin C and
inflammation.
Methods
Study patients
The study was designed as a cross-sectional analysis
including both MHD patients and CAPD patients in
Peking University First Hospital. Patients aged between
18 and 80 years and could provide informed consent
were included. Patients who had autoimmune disease,
malignancy, hepatitis in active conditions, currently used
steroids or immune-suppressants, had positive human
immunodeficiency virus(HIV) serology, and had any
kind of acute infection within one month were excluded.
However, patients having stable cardiovascular disease,
or using central venous catheter, using angiotensin con-
verting enzyme inhibitor (ACEI), angiotensin receptor
antagonist (ARB), or statins were not excluded.
MHD patients were dialyzed three times per week, 4-4.5
hours per session, among them, 54 patients were treated
with conventional hemodialysis (HD), 51 with high-flux
hemodialysis (HFD), and 12 with hemodiafiltration (HDF).
CAPD patients received 3-4 daily exchanges of 2L of peri-
toneal dialysis solution with either 1.5% or 2.5% glucose.
MHD and CAPD patients were classified by vitamin C
level into three subgroups, respectively, according to
previous recommendation [1,2]: group A, or vitamin C
deficiency group, had vitamin C < 2 ug/ml; group B, or
vitamin C insufficiency group, had vitamin C level
between 2-4 ug/ml and group C, or vitamin C normal
or above the normal group, had vitamin C > 4 ug/ml.
This study was approved by the local ethics committee
and written informed consent was obtained from each
participant.
Sample collection and laboratory procedures
Blood samples for vitamin C determination were drawn
from the arteriovenous fistula just before dialysis session
in MHD patients, and from a forearm vein in CAPD
patients. All subjects were in fasting condition. Blood
was collected into heparin-containing tube, and then
was transported in an ice bath to the laboratory. Plasma
was separated by centrifugation (2000 × g, 10 min) at
4°C within 30 minutes, an aliquot of 200 ul plasma was
mixed with 200 ul of 10% metaphosphoric acid (MPA)
and stored at -80°C until analysis within 2 weeks.
Vitamin C was determined by high-performance liquid
chromatography (HPLC) (Agilent 1100 series, Agilent
Technologies, USA) on a Diamonsil C18 column
(150 mm × 4.6 mm, 3 um) at 25°C. For HPLC analysis,
the thawed plasma with MPA was centrifuged at
22000 g for 10 min, 4°C, 20 ul supernatants was injected
into the HPLC by an autosampler. The mobile phase
consisted of 25 mM sodium dihydrogenphosphate pH
2.6, the flow rate was 0.5 mL/min, and observed wave-
length was 244 nm. Intra-assay and inter-assay coeffi-
cients of variation were 2.7% and 2.5%, respectively. The
reference range of vitamin C level in normal population
for this assay was 4-14 mg/L [1,2].
Prealbumin, high-sensitivity C-reactive protein
(hsCRP), albumin, ferritin, calcium, serum bicarbonate,
uric acid and hemoglobin were measured by standard
techniques (the Clinical Laboratory of Peking University
First Hospital, Beijing, China).
Statistical Analysis
The relationships between vitamin C and each of albu-
min, prealbumin and hsCRP levels were tested using
Spearman correlation analysis. Levels of each of vitamin
C, hsCRP, albumin, prealbumin, uric acid, and hemoglo-
bin were compared between MHD and CAPD patients
using t-test. The above parameters were also compared
using one-way analysis of variance (1-way-ANOVA)
among groups A, B and C in each of MHD and CAPD
patients, respectively. Using each of prealbumin, albu-
min and log10hsCRP as outcome and vitamin C as
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structed to explore the relationship between categories
of plasma vitamin C level(< 2 ug/ml,2-4 ug/ml and
> 4 ug/ml) and each of prealbumin, albumin and
log10hsCRP after gender, age, diabetes, modality of dialy-
sis and other confounding effects were adjusted.
Numeric parameters were assessed by c
2 test. Median,
range, percentiles and Kruskal Wallis Test were used for
non-normally distributed variables. Statistical analysis
was performed using SPSS version11.5 (SPSS, Inc.,
Chicago, IL, USA). P values < 0.05 were considered as
statistically significant.
Results
Demographics
The demographics of all the included patients were
listed in table 1. There were 117 MHD patients and 167
CAPD patients, with a mean age of 59.8 ± 13.8 years
and a mean dialysis vintage of 41.8 ± 37.2 months
(median 32, range 1-233 ).
The primary causes of end stage of renal disease
(ESRD) were chronic glomerulonephritis (n = 93),
diabetic nephropathy (n = 57), interstitial nephropathy
(n = 45), hypertensive nephrosclerosis (n = 33), polycys-
tic disease (n = 10), lupus nephropathy (n = 2), chronic
pyelonephritis (n = 1), and others (n = 43).
Compared with CAPD patients, MHD patients had lower
prealbumin, lower serum bicarbonate, higher albumin,
higher systolic blood pressure and longer dialysis vintage.
No statistical significance was found in age, gender and
body mass index between CAPD and MHD patients.
Distribution of plasma vitamin C
Patients showed a widely distribution of plasma vitamin
C levels. The median plasma level was 3.34 ug/ml and
the range from the 25th to the 75th percentile [inter
quartile range (IQR)] was 1.87-5.74 ug/ml. vitamin C
deficiency was present in 95(33.45%) and insufficiency
in 88 ( 30.99% ) of the dialysis patients. 73(25.70%)
patients had plasma vitamin C levels within normal
range and 28(9.86%) at higher than normal levels. There
were 48 patients taking vitamin C supplements (median
100 mg/day, range 50-600 mg/day), among whom,
9 patients with daily vitamin C supplement 50 to
100 mg had plasma vitamin C level less than 4 ug/ml,
and 26 patients with daily vitamin C supplement 300 mg
or more had higher plasma vitamin C level than normal.
Association of vitamin C and prealbumin, albumin, hsCRP
In the total dialysis patients, plasma vitamin C level was
positively associated with prealbumin (Spearman r = 0.268,
P < 0.001), albumin (Spearman r = 0.161, P = 0.007), and
inversely associated with hsCRP (Spearman r = -0.201,
P = 0.001), age (Spearman r = -0.233, P = 0.000). Prealbu-
min is negatively correlated with hsCRP (Spearman
r = -0.331, P < 0.01). No significant association was
found between vitamin C and each of gender, hemoglo-
bin, KT/V, body mass index, ferritin, or dialysis vintage
in our study.
In MHD group, compared with group A, groups B
and C had significantly lower age, higher albumin,
higher prealbumin, and lower hsCRP (table 2) while
gender, body mass index, KT/V and dialysis vintage
were comparable among the three subgroups (table 2).
The similar trend was found in CAPD patients (table 2).
Patients receiving HDF treatment had lower log10hsCRP
value(0.04 ± 0.71) compared with patients receiving HD
treatment(0.52 ± 0.64, P = 0.03). There was no statistical
significance in each of plasma vitamin C level, albumin
and prealbumin among three MHD modalities.
Compared with patients without oral vitamin C supple-
ments, patients with vitamin C supplements had increased
albumin(38.47 ± 3.28 g/L vs 37.00 ± 4.44 g/L, P = 0.04),
not significantly high prealbumin (341.08 ± 65.39 mg/L vs
336.83 ± 101.74 mg/L, P = 0.79), and not significantly low
log10hsCRP(0.28 ± 0.65 vs 0.41 ± 0.69, P = 0.21).
Multivariate analysis for vitamin C effects on prealbumin
and hsCRP levels
In the whole dialysis patients, after adjusting for gender,
age, diabetes and modality of dialysis, systolic blood
pressure, metabolic acidosis and use of statins, per
Table 1 Baseline characteristics of the study population
(n = 284)
Parameters MHD patients
(n = 117)
CAPD patients
(n = 167)
P
value
Age(year) 59.3 ± 13.9 60.2 ± 13.7 0.594
Gender 0.540
Male 45(38.46%) 71(42.52%)
Female 72(61.54%) 96(57.48%)
BMI 22.7 ± 4.3 23.5 ± 3.2 0.071
Diabetes 9/117(7.7%) 48/167(28.7%) 0.000
Prealbumin(mg/l) 285.8 ± 77.3 371.7 ± 94.3 0.000
Albumin(g/l) 38.9 ± 3.9 36.0 ± 4.2 0.000
Uric acid(umol/l) 381.2 ± 82.9 376. 6 ± 79.8 0.642
Haemoglobin(g/l) 110.0 ± 17.2 109.5 ± 12.3 0.806
bicarbonate
(mmol/l)
22.0 ± 3.6 25.7 ± 3.2 0.000
SBP(mmHg) 145.1 ± 19.8 128.9 ± 17.7 0.000
Median(IQR) Median(IQR)
Vitamin C(ug/ml) 2.9(1.6-5.5) 3.0(1.8-5.0) 0.549
hsCRP(mg/l) 2.6 (1.0-6.5) 2.8(1.0-8.2) 0.756
Ferritin(ng/ml) 377(246.9-634.1) 374(215-585) 0.530
Dialysis vintage
(m)
49(20-88) 24(9-49) 0.000
Abbreviation: BMI: body mass index; SBP: systolic blood pressure; IQR: inter
quartile range; hsCRP: high-sensitivity C-reactive protein.
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decrement of log10 (hsCRP), this corresponding to 1.25
(1.12, 1.40) mg/L decrement of hsCRP (P = 0.048),
(table 3).
Plasma vitamin C was positively with prealbumin
levels (P = 0.002) adjusted for hsCRP and above cofac-
tors, prealbumin level was 58.49 ± 12.29 mg/L lower in
patients with vitamin C deficiency compared with
patients with normal vitamin C level.
However, there was no statistical significant associa-
tion between plasma vitamin C and albumin (table 3).
Discussion
In the present study, it was found that vitamin C defi-
ciency and insufficiency was a great problem in our dia-
lysis patients. The results showed that lower plasma
vitamin C level was associated with lower prealbumin
and higher hsCRP concentration both in MHD and in
CAPD patients. These findings collectively suggest that
vitamin C deficiency could be associated with the higher
clinical inflammatory status in our patients.
Patients with active autoimmune disease, malignancy,
hepatitis and acute infection were excluded, because
these kinds of conditions could cause acute oxidative
stress and acute change of hsCRP and vitamin C.
Patients with stable cardiovascular disease, using central
venous catheter, or on regular medication of ACEI, ARB
or statins were not excluded, because we thought these
conditions could not change the relationship between
hsCRP and vitamin C.
W ef o u n di nb o t hM H Da n dC A P Dg r o u p sp l a s m a
vitamin C level was inversely associated with age,
patients with plasma vitamin C < 2 ug/ml(group A) had
older age. And we also found higher hsCRP, lower
albumin and lower prealbumin in such patients, in com-
mon with the results of some previous studies [25,26].
These results may due to a decreasing intake [27], and
an increasing oxidative stress with ageing [28-30].
Numerous studies reported that low plasma level of
vitamin C in dialysis patients is commonly found owing
to loss during dialysis procedure, inadequate dietary
intake, reduced tubular reabsorption and impaired meta-
bolism [3,7,31-33], which was in consistent with our
investigation.
Several clinical studies suggested a linkage between
oxidative stress and inﬂammation in uremic individuals,
but few had focused on the relationship between vita-
min C status and inflammatory indicators, and, if ana-
lyzed, statistical relationship between vitamin C and
each of hsCRP and prealbumin were not obtained in
those previous investigations [4,34,35]. What we
revealed in our study did not parallel these observations.
One important reason is that most of the previous study
patients had daily oral vitamin C supplementation dur-
ing those investigations, which could change the inflam-
matory status. Second, differences in age, smoking
status, dialysis vintage and proportion of diabetes in the
study populations may be responsible for the different
results.
We proposed that the association between vitamin C
and inflammation markers observed in our study was
explained by that inflammation and oxidative stress
have certain internal relations. The oxidative products
such as superoxide anion (O2
-) and hydrogen peroxide
(H2O2) during dialysis procedure could trigger inflam-
mation in uremic patients [10]. On the contrary, oxida-
tive stress may be further aggravated by inflammation
through potentiating respiratory burst activation in
Table 2 Clinical characteristics of three subgroups according to different vitamin C levels in MHD and CAPD groups
MHD group CAPD group
group A group B group C group A group B group C
Parameters < 2 ug/ml(n = 44) 2-4 ug/ml(n = 32) > 4 ug/ml(n = 41) < 2 ug/ml(n = 51) 2-4 ug/ml(n = 56) > 4 ug/ml(n = 60)
Age(year) 66.4 ± 11.3 55.6 ± 12.8
a 54.5 ± 14.5
a 64.9 ± 11.4 57.8 ± 13.7
a 58.4 ± 14.6
b
Gender(male/female) 20/24 13/19 12/29 26/25 23/33 22/38
BMI 22.6 ± 4.5 22.9 ± 4.4 22.5 ± 4.0 24.0 ± 3.3 23.0 ± 2.9 23.6 ± 3.3
KT/V 1.6 ± 0.3 1.6 ± 0.3 1.7 ± 0.2 1.8 ± 0.4 1.9 ± 0.3 1.9 ± 0.4
Diabetes 5/39 1/31 3/38 17/34 18/38 13/47
Vitamin C(ug/ml) 1.2 ± 0.5 2.9 ± 0.6
a 17.9 ± 20.4
ac 1.4 ± 0.4 3.0 ± 0.6
a 10.0 ± 10.6
ac
Prealbumin(mg/l) 250.5 ± 77.2 305.0 ± 72.3
a 309.2 ± 68.0
a 337.7 ± 83.7 371.6 ± 85.7
b 400.2 ± 102.1
a
hsCRP(mg/l) 3.7(1.5-11.6) 1.8(0.7-6.3)
b 2.0(0.4-5.1)
b 4.2(1.9-14.8) 2.1(0.9-6.3)
b 2.1(0.9-5.2)
b
Albumin(g/l) 37.4 ± 4.1 40.6 ± 3.8
a 39.3 ± 3.1
b 34.7 ± 4.6 36.8 ± 3.5
a 36.3 ± 4.2
b
Uric acid(umol/l) 380.3 ± 77.2 397.6 ± 87.4 368.9 ± 82.8 358.1 ± 86.3 380.8 ± 68.6 388.4 ± 82.2
b
Haemoglobin(g/l) 107.5 ± 18.7 117.5 ± 15.0
b 106.7 ± 15.7
c 109.4 ± 13.9 110.8 ± 11.8 108.4 ± 11.5
Ferritin(ng/ml) 412.7 ± 247.2 397.2 ± 209.4 524.5 ± 386.4 508.2 ± 330.7 372.0 ± 294.3
b 427.6 ± 309.3
Dialysis vintage(m) 64.0 ± 48. 2 55.3 ± 37.8 53.3 ± 46.0 27.4 ± 23.1 31.1 ± 26.3 32.6 ± 26.5
aP < 0.01:compared with group A;
bP < 0.05:compared with group A;
cP < 0.01: compared with group B.
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proved that hsCRP had a close correlation with thiobar-
bituric acid reactive substances(TBARS) [5], a marker of
lipid peroxidation, and a-tocopherol, and inflammatory
proteins comprised C-reactive protein, fibrinogen and
a1-antitrypsin were significantly correlated with most
markers of oxidative stress [36]. Jenny M et al [37]
found that acute administration of vitamin C reduced
oxidant stress levels and improved NO-mediated resis-
tance vessel dilatation in renal failure. Kamgar M at al
[38] also showed that MHD patients had a decrease
trend in C-reactive protein compared with the baseline
after given oral vitamin C supplement for 8 weeks
although it did not get statistical significance. However,
Fumeron C et al [39] in a small-scale prospective study
included 33 MHD patients (19 patients with oral vita-
min C 250 mg three times per week after dialysis ses-
sions, 14 patients without oral vitamin C) did not reveal
that vitamin C could ameliorate oxidative stress and
inflammation within 2 months.
Prealbumin is a negative acute-phase protein synthe-
sized primarily by the liver [40], its plasma level
reflects the presence of an ongoing or resolving inflam-
matory condition just as well as C-reactive protein.
Prealbumin serum concentrations may have parallel
changes with protein and energy intakes [41] and
inverse changes in inflammation [42], it was somewhat
equally considered as both markers of nutritional sta-
tus and inflammation. Mehdi Rambod et al [21]
reported in a 798 MHD patients cohort study, prealbu-
min inversely correlated with hsCRP and Interleukin-6
(IL-6), the surrogates of inflammation, which is very
much like our observations.
Lee EJ et al [43] reported that plasma vitamin C levels
positively related to albumin with Serum ascorbic acid
< or = 9 mg/L. In the present investigation, we also
found plasma vitamin C positively related with albumin
in Spearman correlation analysis, but the association did
not exist after adjustment for sex, age, diabetes, mode of
dialysis and other confounding effects. Several recent
documents investigated that plasma vitamin C levels
closely associated with hemoglobin [34], iPTH and alka-
line phosphatase [1]. However, we did not get such find-
ings in both univariate and multivariate analysis in our
sample, which maybe partly explained by the different
selective standard of study population.
Previous study demonstrated that the elimination of
plasma vitamin C is similar in both conventional hemo-
dialysis and on-line hemodiafiltration [44], which is in
line with our findings. In our study, there was no differ-
ence in plasma vitamin C level among the three MHD
modalities. These results may be due to its small mole-
cule (176.1 Da), highly soluble characteristic in water
and low protein-bound. Patients receiving HDF treat-
ment had lower log10hsCRP value compared with
patients receiving HD treatment in our investigation,
this observation was in consistent with some other pre-
vious results [45,46].
Conclusion
In conclusion, our cross-sectional observation indicated
that vitamin C deficiency was prevalent in dialysis
patients, and lower plasma vitamin C level was asso-
ciated with lower serum prealbumin and higher hsCRP
concentration which may be closely link to oxidative
stress and inflammation in uremia. Further large-scale,
long-term interventional clinical trials are required to
Table 3 Association between plasma Vitamin C level and
each of prealbumin, hsCRP and albumin levels adjusted
for cofounders in multiple linear regressions
variable Beta 95%CI t
value
P
value
lower upper
prealbumin VitC(per category
increase)
0.155 7.021 29.477 3.186 0.002
age -0.243 -66.011 -28.674 -4.970 0.000
Diabetes -0.162 -63.307 -15.387 -3.219 0.001
gender 0.125 5.590 44.194 2.528 0.012
modality 0.424 39.327 66.793 7.573 0.000
hsCRP(mg/l) -0.255 -2.888 -1.337 -5.340 0.000
bicarbonate
(mmol/l)
-0.038 -3.561 1.613 -0.738 0.461
SBP(mmHg) 0.030 -0.335 0.627 0.594 0.553
statins 0.175 17.612 59.441 3.611 0.000
Log10hsCRP VitC(per category
increase)
-0.117 -0.195 -0.001 -1.984 0.048
age 0.295 0.249 0.569 5.023 0.000
Diabetes -0.009 -0.224 0.192 -0.152 0.879
gender 0.089 -0.042 0.293 1.472 0.142
modality -0.071 -0.182 0.057 -1.030 0.304
bicarbonate
(mmol/l)
-0.081 -0.037 0.008 -1.295 0.196
SBP(mmHg) -0.220 -0.012 -0.003 -3.581 0.000
statins 0.025 -0.142 0.220 0.421 0.674
albumin VitC(per category
increase)
0.065 -0.246 0.928 1.138 0.256
age -0.252 -3.138 -1.214 -4.432 0.000
Diabetes -0.214 -3.548 -1.035 -3.575 0.000
gender -0.013 -1.127 0.900 -0.219 0.827
modality -0.176 -1.699 -0.252 -2.641 0.009
bicarbonate
(mmol/l)
-0.085 -0.232 0.040 -1.381 0.168
SBP(mmHg) 0.099 -0.004 0.046 1.659 0.098
statins 0.097 -0.148 2.026 1.694 0.091
Abbreviation: Vit C: vitamin C; SBP: systolic blood pressure.
VitC(by categories) deficiency 1, insufficiency 2, normal and above 3; Age(by
categories) < 60y 0, ≥60y 1; Diabetes: non- Diabetes 0, Diabetes 1; gender:
F 0, M 1; modality: HD 1, HDF 2, HFD 3, CAPD 4; statins: without statins 0,
with statins 1.
Zhang et al. BMC Nephrology 2011, 12:18
http://www.biomedcentral.com/1471-2369/12/18
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inflammatory process and improve outcome of dialysis
patients.
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